<p><strong>Alcidion Group Limited</strong> (ASX:ALC) 的股票在过去一个月中继续保持其近期的势头，涨幅达 33%。在最新的上涨之后，年增幅达 122%，引起了投资者的关注。</p>
<p>即使在如此大幅的价格跳升之后，Alcidion Group 目前仍可能被视为一个强劲的买入机会，其市销率（&#34;P/S&#34;）为 4.6 倍，考虑到澳大利亚医疗服务行业中几乎一半的公司市销率超过 15.3 倍，甚至市销率高达 184 倍的情况也并不罕见。不过，仅仅根据市销率来判断并不明智，因为可能有解释说明其如此低的原因。</p>
<p>这项技术可能会取代计算机：发现 20 只正在努力使量子计算成为现实的股票。</p>
<p>查看我们对 Alcidion Group 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/183135443-ps-multiple-vs-industry-1-dark-2/1768420862507?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/183135443-ps-multiple-vs-industry-1-dark-2/1768420862507"/></p>
<p>ASX:ALC 市销率与行业比较 2026 年 1 月 14 日</p>
<h3>Alcidion Group 的表现如何</h3>
<p>Alcidion Group 的表现可能更好，因为它的收入增长低于大多数其他公司。市销率可能较低是因为投资者认为这种乏力的收入表现不会有所改善。如果你仍然喜欢这家公司，你会希望收入不会变得更糟，并且能够在它不受欢迎时买入一些股票。</p>
<p>想要了解分析师对公司的估计的完整情况吗？那么我们对 Alcidion Group 的 <strong>免费</strong> 报告将帮助你揭示未来的趋势。</p>
<h2>收入增长指标告诉我们关于低市销率的什么？</h2>
<p>你唯一会真正感到舒适的情况是，当 Alcidion Group 的市销率如此低迷时，公司的增长显然落后于行业。</p>
<p>如果我们回顾过去一年的收入增长，公司实现了 10% 的可观增长。最近三年期间，收入也整体增长了 19%，在一定程度上得益于其短期表现。因此，我们可以确认公司在这段时间内实际上做得很好，收入增长。</p>
<p>展望未来，覆盖该公司的三位分析师的估计显示，未来三年收入每年应增长 11%。这显然低于更广泛行业的 223% 的年增长预测。</p>
<p>考虑到这一点，显然 Alcidion Group 的市销率低于行业同行的原因。大多数投资者似乎预期未来增长有限，因此只愿意以较低的价格购买该股票。</p>
<h2>我们可以从 Alcidion Group 的市销率中学到什么？</h2>
<p>即使在如此强劲的价格变动之后，Alcidion Group 的市销率仍然落后于行业其他公司。通常情况下，我们会警告在做出投资决策时不要过于解读市销率，尽管它可以揭示其他市场参与者对公司的看法。</p>
<p>我们已经确定 Alcidion Group 维持其低市销率是因为其预测增长低于更广泛的行业，正如预期的那样。现在，股东们接受低市销率，因为他们承认未来的收入可能不会带来任何令人愉快的惊喜。在这种情况下，很难看到股价在不久的将来强劲上涨。</p>
<p>你应该始终考虑风险。举个例子，我们发现了 <strong>1 个警告信号</strong>，你应该注意 Alcidion Group。</p>
<p>重要的是要 <strong>确保你寻找的是一家优秀的公司，而不仅仅是你遇到的第一个想法。</strong> 因此，如果持续盈利符合你对优秀公司的定义，可以查看这份 <strong>免费</strong> 的有趣公司名单，这些公司最近的盈利增长强劲（且市盈率较低）。</p>

<p>Alcidion Group Limited（ASX:ALC）的股价在过去一个月上涨了 33%，年涨幅达到 122%。尽管如此，其市销率（P/S）为 4.6 倍，仍然低于医疗服务行业平均的 15.3 倍。较低的市销率可能反映了投资者对公司收入增长的担忧，预计其增长将落后于行业。分析师预测 Alcidion 的年收入增长为 11%，远低于行业的 223%。这表明未来增长潜力有限，导致投资者情绪谨慎</p>

<p><strong>Alcidion Group Limited</strong> (ASX:ALC) shares have continued their recent momentum with a 33% gain in the last month alone. The annual gain comes to 122% following the latest surge, making investors sit up and take notice.</p>
<div class="lb-trans"><p><strong>Alcidion Group Limited</strong> (ASX:ALC) 的股票在过去一个月中继续保持其近期的势头，涨幅达 33%。在最新的上涨之后，年增幅达 122%，引起了投资者的关注。</p>
</div><p>Even after such a large jump in price, Alcidion Group may still look like a strong buying opportunity at present with its price-to-sales (or &#34;P/S&#34;) ratio of 4.6x, considering almost half of all companies in the Healthcare Services industry in Australia have P/S ratios greater than 15.3x and even P/S higher than 184x aren't out of the ordinary. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's so limited.</p>
<div class="lb-trans"><p>即使在如此大幅的价格跳升之后，Alcidion Group 目前仍可能被视为一个强劲的买入机会，其市销率（&#34;P/S&#34;）为 4.6 倍，考虑到澳大利亚医疗服务行业中几乎一半的公司市销率超过 15.3 倍，甚至市销率高达 184 倍的情况也并不罕见。不过，仅仅根据市销率来判断并不明智，因为可能有解释说明其如此低的原因。</p>
</div><p>This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.</p>
<div class="lb-trans"><p>这项技术可能会取代计算机：发现 20 只正在努力使量子计算成为现实的股票。</p>
</div><p>Check out our latest analysis for Alcidion Group</p>
<div class="lb-trans"><p>查看我们对 Alcidion Group 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/183135443-ps-multiple-vs-industry-1-dark-2/1768420862507" alt="" original-src="https://images.simplywall.st/asset/chart/183135443-ps-multiple-vs-industry-1-dark-2/1768420862507"/></p>
<p>ASX:ALC Price to Sales Ratio vs Industry January 14th 2026</p>
<div class="lb-trans"><p>ASX:ALC 市销率与行业比较 2026 年 1 月 14 日</p>
</div><h3>How Alcidion Group Has Been Performing</h3>
<div class="lb-trans"><h3>Alcidion Group 的表现如何</h3>
</div><p>Alcidion Group could be doing better as it's been growing revenue less than most other companies lately. The P/S ratio is probably low because investors think this lacklustre revenue performance isn't going to get any better. If you still like the company, you'd be hoping revenue doesn't get any worse and that you could pick up some stock while it's out of favour.</p>
<div class="lb-trans"><p>Alcidion Group 的表现可能更好，因为它的收入增长低于大多数其他公司。市销率可能较低是因为投资者认为这种乏力的收入表现不会有所改善。如果你仍然喜欢这家公司，你会希望收入不会变得更糟，并且能够在它不受欢迎时买入一些股票。</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on Alcidion Group will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想要了解分析师对公司的估计的完整情况吗？那么我们对 Alcidion Group 的 <strong>免费</strong> 报告将帮助你揭示未来的趋势。</p>
</div><h2>What Are Revenue Growth Metrics Telling Us About The Low P/S?</h2>
<div class="lb-trans"><h2>收入增长指标告诉我们关于低市销率的什么？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/S as depressed as Alcidion Group's is when the company's growth is on track to lag the industry decidedly.</p>
<div class="lb-trans"><p>你唯一会真正感到舒适的情况是，当 Alcidion Group 的市销率如此低迷时，公司的增长显然落后于行业。</p>
</div><p>If we review the last year of revenue growth, the company posted a worthy increase of 10%. The latest three year period has also seen a 19% overall rise in revenue, aided somewhat by its short-term performance. So we can start by confirming that the company has actually done a good job of growing revenue over that time.</p>
<div class="lb-trans"><p>如果我们回顾过去一年的收入增长，公司实现了 10% 的可观增长。最近三年期间，收入也整体增长了 19%，在一定程度上得益于其短期表现。因此，我们可以确认公司在这段时间内实际上做得很好，收入增长。</p>
</div><p>Shifting to the future, estimates from the three analysts covering the company suggest revenue should grow by 11% per annum over the next three years. That's shaping up to be materially lower than the 223% per year growth forecast for the broader industry.</p>
<div class="lb-trans"><p>展望未来，覆盖该公司的三位分析师的估计显示，未来三年收入每年应增长 11%。这显然低于更广泛行业的 223% 的年增长预测。</p>
</div><p>With this in consideration, its clear as to why Alcidion Group's P/S is falling short industry peers. It seems most investors are expecting to see limited future growth and are only willing to pay a reduced amount for the stock.</p>
<div class="lb-trans"><p>考虑到这一点，显然 Alcidion Group 的市销率低于行业同行的原因。大多数投资者似乎预期未来增长有限，因此只愿意以较低的价格购买该股票。</p>
</div><h2>What We Can Learn From Alcidion Group's P/S?</h2>
<div class="lb-trans"><h2>我们可以从 Alcidion Group 的市销率中学到什么？</h2>
</div><p>Even after such a strong price move, Alcidion Group's P/S still trails the rest of the industry. Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.</p>
<div class="lb-trans"><p>即使在如此强劲的价格变动之后，Alcidion Group 的市销率仍然落后于行业其他公司。通常情况下，我们会警告在做出投资决策时不要过于解读市销率，尽管它可以揭示其他市场参与者对公司的看法。</p>
</div><p>We've established that Alcidion Group maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected. Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises. It's hard to see the share price rising strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>我们已经确定 Alcidion Group 维持其低市销率是因为其预测增长低于更广泛的行业，正如预期的那样。现在，股东们接受低市销率，因为他们承认未来的收入可能不会带来任何令人愉快的惊喜。在这种情况下，很难看到股价在不久的将来强劲上涨。</p>
</div><p>You should always think about risks. Case in point, we've spotted <strong>1 warning sign for Alcidion Group</strong> you should be aware of.</p>
<div class="lb-trans"><p>你应该始终考虑风险。举个例子，我们发现了 <strong>1 个警告信号</strong>，你应该注意 Alcidion Group。</p>
</div><p>It's important to <strong>make sure you look for a great company, not just the first idea you come across.</strong> So if growing profitability aligns with your idea of a great company, take a peek at this <strong>free</strong> list of interesting companies with strong recent earnings growth (and a low P/E).</p>
<div class="lb-trans"><p>重要的是要 <strong>确保你寻找的是一家优秀的公司，而不仅仅是你遇到的第一个想法。</strong> 因此，如果持续盈利符合你对优秀公司的定义，可以查看这份 <strong>免费</strong> 的有趣公司名单，这些公司最近的盈利增长强劲（且市盈率较低）。</p>
</div>

Alcidion Group Limited (ASX:ALC) 股价飙升 33%，但其低市销率并不足以让人感到兴奋